EVP R&D, Chief Medical Officer
Mon, Feb 2, 2026
Feb 2
5,000 shares @ $19.34
Increased holdings by +8.10%
61st largest trade (out of 152)
Cluster Buy
Trade made by an officer
Part of a cluster of 6 transactions by 6 insiders
10b5-1 scheduled trade
35% win rate · -8.7% median edge vs SPY (20 trades, 90-day)
Insider trade was 45% below market price
Price 18% above 200-day moving average